The Vox Markets Podcast
/
Neil Clark & Shaun Claydon of Destiny Pharma: Collaboration for NTCD-M3 worth up to $570m plus royalties
Our new player has been redesigned to fit in better wherever you embed it. Feedback is welcome on our support site.
You can still use our old player if you prefer.